The landscape of blood sugar treatment is advancing with the arrival of transdermal GLP-1 delivery . These convenient delivery systems offer a potentially less invasive alternative to injections for individuals living with type 2 diabetes . These patches deliver glucagon-like peptide-1 directly through the skin , avoiding the need for regular injec